ImageneBio Inc
IMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $949,717 | $986,617 | $1,155,134 | $5,413,523 |
| - Cash | $39,393 | $119,894 | $59,919 | $232,217 |
| + Debt | $7,521 | $10,738 | $5,694 | $6,986 |
| Enterprise Value | $917,845 | $877,461 | $1,100,909 | $5,188,292 |
| Revenue | $3,500 | $9,160 | $15,618 | $30,985 |
| % Growth | -61.8% | -41.3% | -49.6% | – |
| Gross Profit | $3,500 | $8,140 | -$48,703 | -$16,123 |
| % Margin | 100% | 88.9% | -311.8% | -52% |
| EBITDA | -$35,474 | -$74,397 | -$70,153 | -$33,594 |
| % Margin | -1,013.5% | -812.2% | -449.2% | -108.4% |
| Net Income | -$36,568 | -$68,166 | -$68,765 | -$34,115 |
| % Margin | -1,044.8% | -744.2% | -440.3% | -110.1% |
| EPS Diluted | -1.02 | -1.63 | -1.9 | -0.95 |
| % Growth | 37.4% | 14.2% | -100% | – |
| Operating Cash Flow | -$46,004 | -$79,743 | -$74,109 | -$60,252 |
| Capital Expenditures | $0 | -$414 | -$1,431 | -$1,760 |
| Free Cash Flow | -$46,004 | -$80,157 | -$75,540 | -$62,012 |